The Effectiveness of Different Methods for Healing a Palatal Donor Site
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03567148 |
|
Recruitment Status :
Completed
First Posted : June 25, 2018
Last Update Posted : June 25, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Wound Heal Graft Pain Palate; Wound | Procedure: PRF Procedure: Essix retainer Procedure: Ozone therapy Procedure: LLLT Procedure: Collagen fleece | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 90 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Investigator) |
| Primary Purpose: | Treatment |
| Official Title: | Evaluation of The Effectiveness of Different Methods for Healing a Palatal Donor Site After Harvesting a Free Gingival Graft |
| Actual Study Start Date : | January 2017 |
| Actual Primary Completion Date : | December 2017 |
| Actual Study Completion Date : | January 2018 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: PRF group
Four layers of PRF membranes were placed in the palatal wound and sutured with 5/0 resorbable sutures
|
Procedure: PRF
Applying to the palatal wounds
Other Name: medical device |
|
Active Comparator: Essix retainer group
An impression of palatal region was taken and the Essix retainer was prepared before the patients underwent surgery.
|
Procedure: Essix retainer
Applying to the palatal wounds
Other Name: medical device |
|
Active Comparator: Ozone therapy group
Ozone was applied to the donor sites at five different points (four corner-points and a center point) at a fixed concentration of 2100 p.p.m. through a connected hand-piece, using a sterile, specially-formed perio-tip with 80% oxygen for 30 seconds. The applications were performed immediately after surgery and on the 1st, 3rd, and 7th days following the operation.
|
Procedure: Ozone therapy
Applying to the palatal wounds
Other Name: medical device |
|
Active Comparator: LLLT group
Irradiation was performed at the same points described above using a diode laser (λ=970±15 nm, 14-W source power) (SIROLaser Xtend; Sirona Dental Systems GmbH, Bensheim, Germany) that continuously emitted a wavelength with 320µm fiberoptic; the power was 2W and the tissue dose was 35 J/cm2. Total irradiation time was 30 seconds. The applications were performed immediately after surgery, and on the 1st, 3rd and 7th, days following the operation.
|
Procedure: LLLT
Applying to the palatal wounds
Other Name: medical device |
|
Active Comparator: Collagen fleece group
Collagen fleece (BEGO Collagen Fleece, Bremen, Germany) was sutured with 5/0 resorbable sutures (Pegesorb, Istanbul, Turkey) on the open wound with the aid of vertical mattress sutures.
|
Procedure: Collagen fleece
Applying to the palatal wounds
Other Name: medical device |
|
No Intervention: Control group
Palatal wounds were left for spontaneous healing
|
- VAS questionnaire regarding to postoperative pain [ Time Frame: 30th days postoperatively ]The VAS was divided into 10 segments, and the patients were asked to rank their pain level using a scoring system ranging from 0 to 10
- VAS questionnaire regarding to postoperative sensitivity [ Time Frame: 30th days postoperatively ]The VAS was divided into 10 segments, and the patients were asked to rank their sensitivity level using a scoring system ranging from 0 to 10
- hydrogen peroxide test [ Time Frame: 30th days postoperatively ]Epithelization was evaluated using the same time-points by means of bubble formation after dripping hydrogen peroxide (3%) onto the operation site
- VAS questionnaire regarding to changes in eating habits [ Time Frame: 30th days postoperatively ]The VAS was divided into 10 segments, and the patients were asked to rank their eating habits level using a scoring system ranging from 0 to 10
- VAS questionnaire regarding to burning sensation [ Time Frame: 30th days postoperatively ]The VAS was divided into 10 segments, and the patients were asked to rank their sense of burning level using a scoring system ranging from 0 to 10
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 70 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- age >18,
- systemically healthy,
- non-smoker,
- full-mouth plaque and bleeding scores <20%,
- isolated gingival recession defects on the mandibular and maxillary anterior teeth with insufficient keratinized gingiva,
Exclusion Criteria:
- history of mucogingival surgery on the palatal area
- pregnancy
- systemic antibiotics taken for at least six months before the study
- having systemic diseases that could compromise wound healing
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03567148
| Study Director: | Deniz Cetiner, Prof. Dr. | Gazi University |
| Responsible Party: | Sıla Çağrı İşler, Principal Investigator, Gazi University |
| ClinicalTrials.gov Identifier: | NCT03567148 |
| Other Study ID Numbers: |
36290600/114 |
| First Posted: | June 25, 2018 Key Record Dates |
| Last Update Posted: | June 25, 2018 |
| Last Verified: | June 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Graft Pain Palate Wound healing |
|
Wounds and Injuries |

